Klinische Studien zur Angioimmunoblastische Lymphadenopathie mit Dysproteinämie

Insgesamt 261 ergebnisse

    • NCT00169156
      Abgeschlossen
      Bedingungen: Untreated T-cell Angioimmunoblastic Lymphoma
    • NCT03853044
      Rekrutierung
      Bedingungen: Angioimmunoblastic T-cell Lymphoma
    • NCT03273452
      Unbekannter Status
      Bedingungen: Angioimmunoblastic T-cell Lymphoma
    • NCT03593018
      Rekrutierung
      Bedingungen: Relapsed Angioimmunoblastic T-Cell Lymphoma; Refractory Angioimmunoblastic T-cell Lymphoma
    • NCT00958854
      Unbekannter Status
      Bedingungen: Lymphoma
    • NCT00070291
      Beendet
      Bedingungen: Lymphoma
    • NCT02273739
      Abgeschlossen
      Bedingungen: Solid Tumor; Glioma; Angioimmunoblastic T-cell Lymphoma; Intrahepatic Cholangiocarcinoma; Chondrosarcoma
    • NCT04319601
      Rekrutierung
      Bedingungen: Angioimmunoblastic T-cell Lymphoma; Chemotherapy Effect; Chemotherapeutic Toxicity
    • NCT04251065
      Rekrutierung
      Bedingungen: Refractory T-Cell Lymphoma; Relapsed T-Cell Lymphoma
    • NCT02520791
      Aktiv, nicht rekrutierend
      Bedingungen: Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Angioimmunoblastic T-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Angioimmunoblastic T-Cell Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Stage IB Mycosis Fungoides AJCC v7; Stage II Mycosis Fungoides AJCC v7; Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage III Mycosis Fungoides AJCC v7; Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Mycosis Fungoides AJCC v7
    • NCT03070964
      Beendet
      Bedingungen: Lymphoma
    • NCT03703375
      Rekrutierung
      Bedingungen: Lymphoma, T-Cell
    • NCT01553786
      Abgeschlossen
      Bedingungen: T-cell Lymphoma
    • NCT03040206
      Abgeschlossen
      Bedingungen: Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma, ALK-negative
    • NCT00725231
      Unbekannter Status
      Bedingungen: Peripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; Extranodal NK/T-cell Lymphoma
    • NCT03552692
      Beendet
      Bedingungen: T-Cell Lymphoma Relapsed; T-Cell Lymphoma Refractory
    • NCT03590574
      Rekrutierung
      Bedingungen: T Cell Non-Hodgkin Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma
    • NCT01336933
      Abgeschlossen
      Bedingungen: Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma
    • NCT01198665
      Abgeschlossen
      Bedingungen: Peripheral T Cell Lymphoma Unspecified; Anaplastic Large Cell Lymphoma, ALK-negative; Angioimmunoblastic T Cell Lymphoma; Cutaneous T Cell Lymphoma
    • NCT02223208
      Aktiv, nicht rekrutierend
      Bedingungen: Peripheral T-cell Lymphomas (PTCL); PTCL-NOS; Angioimmunoblastic T-cell Lymphoma (AITL); ALK- Anaplastic Large Cell Lymphoma (ALCL); Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin
    • NCT01719835
      Aktiv, nicht rekrutierend
      Bedingungen: Peripheral T-cell Lymphoma NOS; Anaplastic Large Cell Lymphoma, ALK-Negative; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic Gamma/ Delta T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma
    • NCT01336920
      Abgeschlossen
      Bedingungen: Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma
    • NCT03493451
      Aktiv, nicht rekrutierend
      Bedingungen: Peripheral T Cell Lymphoma; PTCL; Extranodal NK/T-cell Lymphoma; Extranodal NK/T-cell Lymphoma, Nasal Type; Extranodal NK T Cell Lymphoma; Extranodal NK T Cell Lymphoma, Nasal; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma Recurrent; Angioimmunoblastic T-Cell Lymphoma Refractory; Peripheral T-cell Lymphoma NOS; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Peripheral T-Cell Lymphoma Refractory; Anaplastic Large Cell Lymphoma; Anaplastic Large Cell Lymphoma, ALK-Positive; Anaplastic Large Cell Lymphoma, ALK-negative; ALK-negative Anaplastic Large Cell Lymphoma; ALK-Positive Anaplastic Large Cell Lymphoma; Cutaneous T-cell Lymphoma
    • NCT02561273
      Aktiv, nicht rekrutierend
      Bedingungen: Anaplastic Large Cell Lymphoma, ALK-Negative; Anaplastic Large Cell Lymphoma, ALK-Positive; Hepatosplenic T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Stage II Angioimmunoblastic T-cell Lymphoma; Stage II Enteropathy-Associated T-Cell Lymphoma; Stage III Angioimmunoblastic T-cell Lymphoma; Stage III Enteropathy-Associated T-Cell Lymphoma; Stage IV Angioimmunoblastic T-cell Lymphoma; Stage IV Enteropathy-Associated T-Cell Lymphoma
    • NCT04795869
      Noch nicht rekrutiert
      Bedingungen: Recurrent Angioimmunoblastic T-Cell Lymphoma; Recurrent Enteropathy-Associated T-Cell Lymphoma; Recurrent Follicular T-Cell Lymphoma; Recurrent Hepatosplenic T-Cell Lymphoma; Recurrent Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified; Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma; Refractory Angioimmunoblastic T-Cell Lymphoma; Refractory Enteropathy-Associated T-Cell Lymphoma; Refractory Follicular T-Cell Lymphoma; Refractory Hepatosplenic T-Cell Lymphoma; Refractory Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified; Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma